BFB Health Limited has dispatched its circular for the Annual General Meeting (AGM) scheduled on 30 June 2026 at 3:00 p.m. in Hong Kong. Key resolutions focus on capital management authorities, board composition, and auditor continuity.

The board will request shareholder approval for: 1. A renewed general mandate to issue up to 20% of the company’s existing share capital, equal to a ceiling of 250.24 million new shares based on the 1.25 billion shares outstanding as of 22 April 2026. 2. A repurchase mandate permitting buy-backs of up to 10% of issued shares, or 125.12 million shares, during the mandate period. Shares repurchased may be cancelled or held as treasury stock subject to regulatory rules. 3. An extension allowing shares repurchased under the buy-back mandate to be added to the shares available for re-issue, effectively raising the potential issuance headroom beyond the 20% base limit.

Board changes include the scheduled retirement and proposed re-election of Executive Directors Mr Li Leong and Mr Wu Mansheng, alongside Independent Non-executive Director Mr Law Chi Hung. Brief biographies and current shareholdings are provided in the circular; Mr Wu holds 217.00 million shares, or 17.34% of the company, while Mr Law holds options over 7.30 million shares (0.25%).

Infinity CPA Limited is nominated for re-appointment as external auditor for the year ending 31 December 2026, with an estimated audit fee of HK$0.58 million.

Shareholders intending to attend or vote must ensure transfers are lodged by 4:30 p.m. on 24 June 2026, as the register will close from 25 June to 30 June 2026. All AGM resolutions will be decided by poll.